Cell Therapeutics Inc, Ortho Biotech Inc., R. W. Johnson Pharmaceuticals Research Institute deal

CTIC and the two Johnson & Johnson subsidiaries expanded their 1996 agreement to develop lisofylline, an inhibitor of phosphatidic acid, to

Read the full 219 word article

How to gain access

Continue reading with a
two-week free trial.